The predictive role of early activation of natural killer cells in septic shock

  • Raúl de Pablo1, 2Email author,

    Affiliated with

    • Jorge Monserrat2Email author,

      Affiliated with

      • Carolina Torrijos2,

        Affiliated with

        • Mercedes Martín2,

          Affiliated with

          • Alfredo Prieto2 and

            Affiliated with

            • Melchor Alvarez-Mon2, 3

              Affiliated with

              Critical Care201216:413

              DOI: 10.1186/cc11204

              Published: 7 March 2012

              Abstract

              Recently, several studies about the role of natural killer (NK) cells in sepsis have been highlighted. In an earlier study, we characterized the abnormalities of circulating lymphocytes in 52 patients with septic shock during the first 28 days in the intensive care unit. Our results confirm and expand some previous reports. We found that patients who did not survive exhibited less NK cell (CD3CD56+) depletion than survivors and that these NK cells expressed CD69+ and CD57+. These data demonstrate that NK cells are key participants in septic shock because patients who survived have more depletion and expressed less early activation and differentiation.

              In a study that was published in a recent issue of Critical Care and that was conducted in a cohort of 50 patients with severe sepsis at intensive care unit (ICU) admission, Andaluz-Ojeda and colleagues [1] reported that absolute counts and relative concentrations of natural killer (NK) cells were significantly higher in patients who died.

              In an earlier study, also published in Critical Care, we characterized the abnormalities of lymphocytes in 52 patients with septic shock during the first 28 days in the ICU [2]. Thirty-six healthy subjects served as controls. The study design was approved by the university hospital ethics committee, and all participants or their next of kin provided written informed consent.

              Table 1 shows the significant differences found in the counts and percentages of lymphocyte subpopulations during the first week of follow-up. Like previous investigators, we have found a reduced count of circulating NK cells in patients with septic shock, independently of their outcome [1, 3]. Although patients who did not survive exhibited less NK cell depletion than survivors at ICU admission, there were no differences in CD56+CD3- cell counts in blood between survivors and non-survivors. These data are slightly in agreement with those reported by Andaluz-Ojeda and colleagues [1], who found that patients with the highest NK cell number had the lowest probability to survive. However, unlike Giamarellos-Bourboulis and colleagues [4], we did not find higher percentages of NK cells in patients who did not survive.
              Table 1

              Counts and percentages of lymphocytes and their main subpopulations during the first week of follow-up in patients with septic shock and in healthy controls

                 

              At ICU admission

              After 48 hours

              On 7th day

                

              Healthy controls

              Non-survivors

              Survivors

              Non-survivors

              Survivors

              Non-survivors

              Survivors

              Lymphocytes

              Count

              2,095.9 ± 67.0

              1,235.3 ± 178.9a

              1,048.4 ± 192.0a

              1,235.3 ± 178.9a

              1,048.4 ± 192.0a

              863.3 ± 36.6a

              886.2 ± 178.9a

               

              Percentage

              30.4 ± 2.0

              7.0 ± 1.7a

              4.6 ± 0.7a

              9.5 ± 0.4a,b

              5.0 ± 1.1a

              4.4 ± 0.9a

              5.8 ± 0.9a

              CD3+

              Count

              1,393.6 ± 36.1

              745.9 ± 145.7a

              740.0 ± 151.8

              800.1 ± 10.2a

              558.9 ± 170.1a

              712.8 ± 69.7a

              574.9 ± 147.6a

               

              Percentage

              71.4 ± 1.7

              59.9 ± 6.1

              65.9 ± 4.2

              70.0 ± 0.8

              56.7 ± 8.9

              73.1 ± 5.9

              63.8 ± 4.6

              CD19+

              Count

              238.5 ± 13.2

              259.8 ± 83.8

              162.8 ± 36.3

              170.2 ± 4.0

              199.3 ± 64.2

              131.7 ± 83.9

              112.2 ± 23.4a

               

              Percentage

              10.7 ± 0.9

              21.8 ± 6.9

              15.9 ± 3.0

              16.2 ± 0.63a

              18.7 ± 2.2a

              14.2 ± 9.5

              14.3 ± 2.3

              CD56+CD3

              Count

              356.8 ± 28.4

              191.8 ± 46.8a

              127.7 ± 30.3a

              125.3 ± 4.0a

              120.1 ± 53.3a

              83.8 ± 47.0a

              116.6 ± 36.6a

               

              Percentage

              16.8 ± 1.9

              16.1 ± 3.3

              18.6 ± 2.9

              14.0 ± 0.82

              12.5 ± 3.7

              7.9 ± 3.9

              13.2 ± 2.2

              Using CD69 and CD57 surface antigens, we determined the counts and distributions of the activation stage of NK cells (CD3CD56+) by flow cytometry. We obtained a significant increase in the counts and percentages of the CD3CD56+CD69+ cells in non-survivors at ICU admission and on day 3 (Figure 1). The mean fluorescence intensity for CD56+CD3CD69+ cells was also significantly higher in non-survival patients than in survivors or controls (30.6 ± 4.2 versus 20.3 ± 2.6 and 18.3 ± 0.9, respectively; P < 0.05 for both). CD69 is rapidly induced in NK cells after activation and its role in NK cytotoxicity has been demonstrated in humans [5].
              http://static-content.springer.com/image/art%3A10.1186%2Fcc11204/MediaObjects/13054_2012_9914_Fig1_HTML.jpg
              Figure 1

              Kinetics of circulating blood percentage of total natural killer (NK) cells (A) and counts (B) of CD3 CD56 + CD69 + NK subset in patients with septic shock during their stay in the intensive care unit. Values are expressed as the mean percentage ± standard deviation (A) or as the mean of cells per microliter ± standard deviation (B). Data from non-survival patients, survivors, and healthy control subjects are shown in red, green, and blue, respectively. The Mann-Whitney U test for non-parametric data was used to analyze differences between the groups, and analysis of variance followed by Wilcoxon signed-rank tests were used for within-group analyses. *P < 0.05 for survivors or non-survivors versus controls; P < 0.05 for survivors versus non-survivors; P < 0.05 for each follow-up time versus intensive care unit admission.

              We further found a significantly higher percentage of CD3CD56+CD57+ NK cells in non-survival patients than in survivors and controls at ICU admission (70.8% ± 3.3% versus 57.3% ± 9.2% and 53.6% ± 3.7%, respectively; P < 0.05). Non-survivors had a strong but not significant trend toward an increase of CD3CD56+CD57+ NK cell count (94.8 ± 7.3 versus 56.9 ± 12.4 cells per cubic millimeter). The expression of CD57, a long-lived marker and highly differentiated effector of NK cells, is increased in septic shock patients who died.

              These data demonstrate an important role of NK cells as key participants in the early inflammatory response during septic shock. Patients who did not survive exhibited less NK cell depletion than survivors and these cells were very early activated and rapidly differentiated. We propose to asses NK cell phenotype and functions for a better understanding of the physiopathology of sepsis in order to apply new therapies at an early stage.

              All values are expressed as mean ± standard deviation. 'Count' values are presented as cells per cubic millimeter, and 'Percentage' values are presented as percentages. The Mann-Whitney U test for non-parametric data was used to analyze differences between the groups. a P < 0.05 between septic shock patients and healthy controls. b P < 0.05 between survival and non-survival patients with septic shock. ICU, intensive care unit.

              Abbreviations

              ICU: 

              intensive care unit

              NK: 

              natural killer.

              Declarations

              Authors’ Affiliations

              (1)
              Intensive Care Unit, Hospital Universitario Príncipe de Asturias, Carretera Alcalá-Meco
              (2)
              Laboratory of Immune System Diseases and Oncology, National Biotechnology Center (CNB-CSIC) Associated Unit, Department of Medicine, Campus Universitario, Carretera Madrid-Barcelona
              (3)
              Immune System Diseases and Oncology Service, Hospital Universitario Príncipe de Asturias, Carretera Alcalá-Meco

              References

              1. Andaluz-Ojeda D, Iglesias V, Bobillo F, Almansa R, Rico L, Gandía F, Loma AM, Nieto C, Diego R, Ramos E, Nocito M, Resino S, Eiros JM, Tamayo E, de Lejarazu RO, Bermejo-Martin JF: Early natural killer cell counts in blood predict mortality in severe sepsis. Crit Care 2011, 15:R243.PubMedView Article
              2. Monserrat J, de Pablo R, Reyes E, Díaz D, Barcenilla H, Zapata MR, De la Hera A, Prieto A, Alvarez-Mon M: Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Crit Care 2009, 13:R26.PubMedView Article
              3. Venet F, Davin F, Guignant C, Larue A, Cazalis MA, Darbon R, Allombert C, Mougin B, Malcus C, Poitevin-Later F, Lepape A, Monneret G: Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 2010, 34:358–363.PubMedView Article
              4. Giamarellos-Bourboulis EJ, Tsaganos T, Spyridaki E, Mouktaroudi M, Plachouras D, Vaki I, Karagianni V, Antonopoulou A, Veloni V, Giamarellou H: Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Crit Care 2006, 10:R166.PubMedView Article
              5. Borrego F, Robertson MJ, Ritz J, Pena J, Solana R: CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology 1999, 97:159–165.PubMedView Article

              Copyright

              © BioMed Central Ltd 2012

              Advertisement